Title:
CDISC Members Only Mini-Training Series - Deconstructing ADRS: Tumor Response Analysis Data Set
Description:
From the perspective of someone new to both the oncology therapy area and ADaM, this presentation describes the experience of working with an already-existing data set used for the analysis of tumor responses. Progressively detailed analysis needs of a protocol are explained along with their impact on the design of the ADaM data set, in terms of structure and derived parameters. No prior knowledge of oncology studies or tumor data domains is necessary, as concepts will be explained throughout and the focus will be on the ADaM implementation and lessons learned.
Agenda:
• Deconstructing ADRS: Tumor Response Analysis Data Set
Presenter:
• Steve Almond, Lead Statistical Analyst, Bayer
Q&A Panelists:
• Nate Freimark, Senior Director of the Biometrics Operations Standards Group, Theorem Clinical Research
• Susan Kenny, President, Maximum Likelihood
• Mario Widel, Research Scientist, Eli Lilly and Company